Every day tech, like your smartphone or computer, can help manage wet AMD through built-in accessibility features such as voice commands, screen magnification, and high-contrast settings.
– Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in wet AMD, the leading cause of vision loss in people over the age of 60 – – With two refills per ...
Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...
—A new analysis took a 2-prong approach to assessing risk factors for wet age-related macular degeneration: a systematic review of the literature, coupled with a study of decades’ worth of data from ...
ROCKVILLE, Md., Oct. 6, 2025 /PRNewswire/ -- REGENXBIO Inc. (RGNX) today announced the completion of enrollment in the ATMOSPHERE ® and ASCENT ® pivotal studies evaluating surabgene lomparvovec ...
ORLANDO ‑- Cataract surgery was linked to an increased risk of conversion from dry to neovascular (wet) age-related macular degeneration (AMD) in a large retrospective cohort study, although the ...
The FDA's complete response letter highlights insufficient efficacy evidence for bevacizumab-vikj in treating wet AMD, despite previous safety confirmations. NORSE EIGHT study failed its primary ...
Hosted on MSN
OCUL stock surges overnight ahead of crucial wet AMD data readout, Sanofi takeover buzz builds
・The company is set to release topline results from its Phase 3 superiority trial of Axpaxli in wet AMD on Tuesday. ・Ocular previously said that positive results could support a New Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results